Meridian Therapeutics is categorized under Acupuncturists in Vancouver, WA and active since 2007.
Meridian Therapeutics was established in 2007, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Acupuncturists business, which does work in the B2C market, and is classified as a Acupuncturists, under code number 6213990 by the NAICS.
If you are seeking more information, feel free to contact Ivan Cheng, Owner at the company’s single location by writing to 3425 Se 192nd Avenue # 109, Vancouver, Washington WA 98683 or by phoning (360) 253-7696. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Meridian Therapeutics |
| Contact Person: | Ivan Cheng, Owner |
| Address: | 3425 Se 192nd Avenue # 109, Vancouver, Washington 98683 |
| Phone Number: | (360) 253-7696 |
| Website Address: | mtherapeutics.com |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2007 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Acupuncturists |
| SIC Code: | 8049 |
| NAICS Code: | 6213990 |
| Share This Business: |
Meridian Therapeutics was started in 2007 to provide professional Acupuncturists under the SIC code 8049 and NAICS code 6213990. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Ivan Cheng, Owner for inquiries that concern Meridian Therapeutics by calling the company number (360) 253-7696, as your correspondence is most welcome. Additionally, the physical location of the single location of Meridian Therapeutics can be found at the coordinates 45.59556,-122.47799 as well as the street address 3425 Se 192nd Avenue # 109 in Vancouver, Washington 98683.
For its online presence, you may visit Meridian Therapeutics’s website at mtherapeutics.com and engage with its social media outlets through on Twitter and on Facebook.